Literature DB >> 31139951

The factors affecting the disease course in Kawasaki disease.

Elif Arslanoglu Aydin1, Ilker Ertugrul2, Yelda Bilginer3, Ezgi Deniz Batu3, Hafize Emine Sonmez3, Selcan Demir3, Zehra Serap Arici3, Erdal Sag3, Dursun Alehan2, Seza Ozen4.   

Abstract

The aim of this study was to review the characteristics of patients with Kawasaki disease (KD) from Turkey and to assess the performance of the Kobayashi score (KS), Harada score (HS), Formosa score (FS), Egami score (ES) and other parameters in predicting intravenous immunoglobulin (IVIG) resistance and coronary artery involvement (CAI) in the Turkish population. Patients who were diagnosed as being in the acute phase of KD at Hacettepe University Faculty of Medicine (Ankara, Turkey) between June 2007 and January 2016 reviewed retrospectively, and those between January 2016 and February 2018 reviewed prospectively, were included in this cohort study. A total of 100 patients with KD were included in this study. Statistical Package for Social Sciences for Windows 22.0 (SPSS Inc, Chicago, IL, USA) was used for statistical analysis. Eighty-five patients (85%) responded to IVIG treatment, whereas 15 (5 female, 10 male) were IVIG resistant. CAI was detected in echocardiography at diagnosis in 31 (31%) (9 female; 22 male) patients. For predicting IVIG resistance, KS, ES, FS, and HS had sensitivity of 82.1%, 26.7%, 30.8%, 69.2% and specificity of 35.7%, 94%, 51.2%, 45.8%, respectively. For the association with CAI occurrence, the sensitivities were 17.2%, 3.3%, 35.7%, 70.4% and the specificities were 78.5%, 88.4%, 49.3%, 49.3% for the aforementioned scores, respectively. The multivariate analysis showed white blood cell (WBC) count [Odd's ratio (OR) 4.1; 95% confidence interval (CI) 1.26-13.23; p = 0.019] and hematocrit (OR 3.8; 95% CI 1.15-12.4; p = 0.028), as independent predictors of CAI while gamma-glutamyl transferase (GGT) level (OR 5.7; 95% CI 1.73-27.51; p = 0.018) was detected as the only independent predictor of IVIG resistance. This is the first study from Turkey in KD to evaluate the association of the scoring systems for IVIG resistance and CAI. The risk scoring systems in KD did not predict the risk for IVIG resistance and were not associated with CAI in Turkish population.

Entities:  

Keywords:  Coronary artery aneurysm; Echocardiography; IVIG resistance; Kawasaki disease; Predictive score

Mesh:

Substances:

Year:  2019        PMID: 31139951     DOI: 10.1007/s00296-019-04336-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  32 in total

Review 1.  Pediatric vasculitis.

Authors:  Ezgi Deniz Batu; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

2.  Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.

Authors:  Daisuke Sudo; Yoshiro Monobe; Mayumi Yashiro; Atsuko Sadakane; Ritei Uehara; Yosikazu Nakamura
Journal:  Pediatr Int       Date:  2010-10       Impact factor: 1.524

Review 3.  Kawasaki disease: an update on diagnosis and treatment.

Authors:  Ho-Chang Kuo; Kuender D Yang; Wei-Chiao Chang; Luo-Ping Ger; Kai-Sheng Hsieh
Journal:  Pediatr Neonatol       Date:  2012-01-17       Impact factor: 2.083

4.  Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.

Authors:  Kimiyasu Egami; Hiromi Muta; Masahiro Ishii; Kenji Suda; Yoko Sugahara; Motofumi Iemura; Toyojiro Matsuishi
Journal:  J Pediatr       Date:  2006-08       Impact factor: 4.406

5.  Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance.

Authors:  Lynn A Sleeper; L Luann Minich; Brian M McCrindle; Jennifer S Li; Wilbert Mason; Steven D Colan; Andrew M Atz; Beth F Printz; Annette Baker; Victoria L Vetter; Jane W Newburger
Journal:  J Pediatr       Date:  2010-12-18       Impact factor: 4.406

6.  Epidemiology of Kawasaki disease: prevalence from national database and future trends projection by system dynamics modeling.

Authors:  San-Kuei Huang; Min-Tai Lin; Hui-Chi Chen; Shin-Chung Huang; Mei-Hwan Wu
Journal:  J Pediatr       Date:  2013-01-11       Impact factor: 4.406

7.  Intravenous gamma-globulin treatment in Kawasaki disease.

Authors:  K Harada
Journal:  Acta Paediatr Jpn       Date:  1991-12

8.  Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003.

Authors:  Ermias D Belay; Ryan A Maddox; Robert C Holman; Aaron T Curns; Konique Ballah; Lawrence B Schonberger
Journal:  Pediatr Infect Dis J       Date:  2006-03       Impact factor: 2.129

Review 9.  [Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease].

Authors:  Tohru Kobayashi; Yoshinari Inoue; Akihiro Morikawa
Journal:  Nihon Rinsho       Date:  2008-02

10.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01
View more
  2 in total

1.  Kawasaki disease recognition and treatment.

Authors:  Kimberly A Morishita; Ran D Goldman
Journal:  Can Fam Physician       Date:  2020-08       Impact factor: 3.275

2.  Kawasaki-like disease in children with COVID-19.

Authors:  Ummusen Kaya Akca; Selman Kesici; Yasemin Ozsurekci; Hayrettin Hakan Aykan; Ezgi Deniz Batu; Erdal Atalay; Selcan Demir; Erdal Sag; Dogus Vuralli; Benan Bayrakci; Yelda Bilginer; Seza Ozen
Journal:  Rheumatol Int       Date:  2020-09-16       Impact factor: 3.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.